A189 A RETROSPECTIVE ANALYSIS OF OUTCOMES ASSOCIATED WITH PEGYLATED-INTERFERON (PEG-IFN) TREATMENT IN CHRONIC HEPATITIS B (CHB)

摘要

BackgroundPEG-IFN is first-line therapy for CHB offering the advantage of a finite treatment, but is rarely used due to concerns about tolerability and efficacy. Nucleot(s)ide analogues (NUC) therapy are well tolerated but require prolonged therapy, with significant cost as well as potential for long-term adverse effects.